New-onset diabetes in COVID-19: The molecular pathogenesis.

Wihandani, Desak Made; Purwanta, Made Lady Adelaida; Mulyani, W Riski Widya; Putra, I Wayan Ardyan Sudharta; Supadmanaba, I Gede Putu

Wihandani, Desak Made; Purwanta, Made Lady Adelaida; Mulyani, W Riski Widya; Putra, I Wayan Ardyan Sudharta; Supadmanaba, I Gede Putu.

Afiliação

Wihandani DM; Department of Biochemistry, Faculty of Medicine Udayana University, Sanglah General Hospital, Denpasar, Bali, Indonesia.
Purwanta MLA; Department of Biochemistry, Faculty of Medicine Udayana University, Sanglah General Hospital, Denpasar, Bali, Indonesia.
Mulyani WRW; Department of Biochemistry, Faculty of Medicine Udayana University, Sanglah General Hospital, Denpasar, Bali, Indonesia.
Putra IWAS; Department of Biochemistry, Faculty of Medicine Udayana University, Sanglah General Hospital, Denpasar, Bali, Indonesia.
Supadmanaba IGP; Department of Biochemistry, Faculty of Medicine Udayana University, Sanglah General Hospital, Denpasar, Bali, Indonesia.

Biomedicine (Taipei) ; 13(1): 3-12, 2023.

Article em En | MEDLINE | ID: mdl-37168726

Palavras-chave

ACE2; COVID-19; Diabetes; SARS coronavirus

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies Idioma: En Revista: Biomedicine (Taipei) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Indonésia País de publicação:

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google